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Why Is Infant Mortality Higher  
in the United States than in Europe?†
By Alice Chen, Emily Oster, and Heidi Williams*
The United States has higher infant mortality than peer countries. 
In this paper, we combine microdata from the United States with 
similar data from four European countries to investigate this US 
infant mortality disadvantage. The US disadvantage persists after 
adjusting for potential differential reporting of births near the 
threshold of viability. While the importance of birth weight varies 
across comparison countries, relative to all comparison countries the 
United States has similar neonatal (<1 month) mortality but higher 
postneonatal (1–12  months) mortality. We document similar patterns 
across census divisions within the United States. The postneonatal 
mortality disadvantage is driven by poor birth outcomes among 
lower socioeconomic status individuals. (JEL I12, I14, I32, J14)
In 2013, the US infant mortality rate (IMR) ranked 51st internationally, compara-ble to Croatia, despite an almost three-fold difference in gross domestic product 
(GDP) per capita.1 One way to quantify the magnitude of this infant mortality disad-
vantage is to consider that the US IMR is about three deaths per 1,000 greater than in 
Scandinavian countries. Aggregating 4 million annual US births and taking a standard 
value of life estimate of US$7 million (Viscusi and Aldy 2003) suggests that reducing 
the US IMR to that of Scandinavian countries would be worth on the order of US$84 
billion annually. By this metric, it would be “worth it” to spend up to $21,000 on each 
live birth to lower the infant mortality risk to the level in Scandinavia.
1 Croatia’s IMR in 2013 was 5.96, relative to 5.9 in the United States; GDP per capita was $18,100 in Croatia 
and $50,100 in the United States (Central Intelligence Agency (CIA) 2013). 
* Chen: Sol Price School of Public Policy, Verna and Peter Dauterive Hall (VPD) 212D, 635 Downey Way, Los 
Angeles, CA 90089 (e-mail: alicejc@price.usc.edu); Oster: Department of Economics, Brown University, Box B, 
Robinson Hall, 64 Waterman Street, Providence, RI 02912 and National Bureau of Economic Research (NBER) 
(e-mail: Emily_Oster@brown.edu); Williams: Department of Economics, Massachusetts Institute of Technology 
(MIT), 77 Massachusetts Avenue E17-222, Cambridge, MA 02139, and NBER (e-mail: heidiw@mit.edu). We thank 
Franz Bilek, Anita Mikulasek, and Ursula Shuster for assistance in accessing the Austrian data; and Gissler Mika, 
Irmeli Penttilä, and Arto Vuori for assistance in accessing the Finnish data. We gratefully acknowledge comments 
from Dan Fetter, Amy Finkelstein, Michael Greenstone, Amanda Kowalski, Doug Miller, and seminar participants 
at Brown University, the NBER Health Care meeting, MIT, Northwestern University, University of California, Los 
Angeles (UCLA), University of Chicago, University of Michigan, Stanford University, and Wharton School of the 
University of Pennsylvania; research assistance from Toby Chaiken, Hailey Nguyen, and Sophie Sun; and financial 
support from the Neubauer Family (Oster), National Institute on Aging (NIA) Grant Number T32-AG000186 to the 
NBER (Williams), and National Science Foundation (NSF) Grant Number 1151497 (Williams).
† Go to http://dx.doi.org/10.1257/pol.20140224 to visit the article page for additional materials and author 
disclosure statement(s) or to comment in the online discussion forum.
90 AmErIcAn EconomIc JoUrnAL: EconomIc PoLIcy mAy 2016
While the US IMR disadvantage is widely discussed and quantitatively import-
ant, the determinants of this disadvantage are not well understood, hindering policy 
efforts.2 A key constraint on past research has been the lack of comparable micro-
datasets across countries. Cross-country comparisons of aggregate infant mortality 
rates provide very limited insight, for two reasons. First, a well-recognized problem 
is that countries vary in their reporting of births near the threshold of viability. Such 
reporting differences may generate misleading comparisons of how infant mortal-
ity varies across countries. Second, even within a comparably-reported sample, the 
observation that mortality rates differ one year post-birth provides little guidance 
on what factors are driving the US disadvantage. As a specific example, although a 
large literature has documented significant inequality in infant mortality outcomes 
across socioeconomic groups within the United States (i.e., Currie, Shields, and 
Price 2007; Case, Lubotsky, and Paxson 2002; Miller 2003), it is less clear how 
much of the cross-country US IMR disadvantage is explained by higher levels of 
inequality within the United States.
We begin in this paper by relaxing this data constraint. We combine US natal-
ity microdata with similar microdata from Finland and Austria. In addition, we 
use data from the United Kingdom and Belgium which can be restricted to a 
 comparably-reported sample and reported in aggregated cells based on birth weight 
and age at death. Using these data, we provide a detailed accounting of the US IMR 
disadvantage relative to these European comparisons, quantifying the importance 
of differential reporting, some conditions at birth (specifically, birth weight and 
gestational age), neonatal mortality (deaths in the first month), and postneonatal 
mortality (deaths in months 1 to 12). To the best of our knowledge, cross-country 
microdata has not previously been used to undertake this type of exercise.
This exercise yields a number of findings. First, consistent with past evidence 
(MacDorman and Mathews 2009), differential reporting of births cannot offer a 
complete explanation for the US IMR disadvantage. However, accounting for dif-
ferential reporting is quantitatively important. Compared to the average of the five 
European countries we analyze, limiting to a comparable sample lowers the appar-
ent US IMR disadvantage from 2.5 deaths per 1,000 births to 1.5 deaths. This find-
ing highlights the importance of conducting cross-country comparisons in a setting 
where reporting differences can be addressed, which is typically not possible in the 
types of aggregate statistics compiled by the World Health Organization (WHO) 
and the World Development Indicators (WHO 2006; World Bank 2013).
Second, we explore the importance of differences in health at birth. Worse health 
at birth is widely cited as the major driver of the US IMR disadvantage (MacDorman 
and Mathews 2009, National Research Council 2013, Wilcox et al. 1995); we are 
able to investigate this issue after restricting attention to our comparably-reported 
sample. Consistent with past evidence that has focused on comparing the United 
States with Scandinavian countries, we find that birth weight can explain around 
2 Economists have not written much on cross-country differences in infant mortality; when they have, it has 
often focused (most notably, Waldmann 1992) on the relationship with income levels and income inequality across 
countries. The proximate causes of the US infant mortality disadvantage have been of more interest in the public 
health literature. 
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75 percent of the US IMR disadvantage relative to Finland or Belgium. However, 
birth weight can only explain 30 percent of the US IMR disadvantage relative to 
Austria or the United Kingdom. Moreover, even normal birth weight infants have a 
substantial IMR disadvantage—2.3 deaths per 1,000 in the United States, relative to 
1.3 in Finland, 1.5 in Austria, 1.6 in the United Kingdom, and 2.0 in Belgium.
Third, our data allow us to distinguish between neonatal and postneonatal deaths 
in our comparably-reported sample. The neonatal/postneonatal distinction is infor-
mative because the relevant causes of death during these two time periods are 
quite different (Rudolph and Borker 1987). Previous comparisons of neonatal and 
postneonatal mortality in aggregate data (such as Kleinman and Kiely 1990) are 
difficult to interpret given the differential reporting concern: specifically, in an unre-
stricted sample the United States has much higher neonatal mortality than any of 
the European comparisons we analyze (WHO 2006), whereas our comparably-re-
ported sample suggests that differences in reporting could be driving nearly all of 
that pattern.
In our comparably-reported sample, the US neonatal mortality disadvantage is 
quantitatively small and appears to be fully explained by differences in birth weight. 
In contrast, the United States has a substantial disadvantage relative to all com-
parison countries during the postneonatal period even in our comparably-reported 
sample and even conditional on circumstances at birth. A simple illustration for the 
three countries with microdata (the United States, Finland, and Austria) can be seen 
in Figure 1, which shows the cumulative probability of death over the first year. The 
infant mortality rate in the United States is higher at all ages, but this difference 
accelerates after the first month of life. Importantly, this excess postneonatal mortal-
ity does not appear to be driven by the United States “delaying” neonatal deaths: the 
postneonatal disadvantage appears strongly even among normal birth weight infants 
and those with high Apgar scores.
Hence, our cross-country analysis points to the importance of the postneonatal 
period as a driver of the US disadvantage and, on its own, may suggest support 
for policies which target this period of life. In the second part of the paper, we 
expand our analysis to consider geographic variation in infant mortality within the 
United States, focusing on the nine US census divisions. If the lowest mortality 
census division (the Northeast) were a country on its own, it would have a mortality 
rate very similar to Austria. In contrast, the worst off census division (East South 
Central) has a one-year mortality rate twice as high as the Northeast. Replicating our 
 cross-country decomposition across US census regions again uncovers an important 
role for the postneonatal period: only 39 percent of deaths in the lowest-mortal-
ity census division occur in the postneonatal period, but deaths during this period 
account for 67 percent of the geographic differences in mortality. Reducing postneo-
natal mortality in each census division to the level observed in the lowest-mortality 
division would reduce mortality rates, on average, by 0.72 deaths per 1,000 births.
In the final section of the paper, we use a subset of the cross-country data, together 
with the within-US variation, to analyze the socioeconomic profile of the postneo-
natal mortality gaps. It is well known that infant mortality in the United States var-
ies strongly across socioeconomic groups (as documented by, for example, Case, 
Lubotsky, and Paxson 2002). Given this, a natural question is whether the US 
92 AmErIcAn EconomIc JoUrnAL: EconomIc PoLIcy mAy 2016
IMR disadvantage relative to Europe is accounted for by higher cross-group IMR 
inequality in the United States relative to Europe, or whether even highly advan-
taged Americans are in worse health than their counterparts in peer countries (as 
National Research Council 2013 argues). We can ask a similar question about the 
 cross-regional differences in the United States. Our demographic data in Europe are 
limited to Austria and Finland so we focus on those two countries as our comparison.
We first approach this question nonparametrically by estimating 
 birthweight-adjusted postneonatal death rates by country (or census division) and 
demographic group. We find that infant mortality differences, both across countries 
and across regions within the United States, are driven by lower socioeconomic 
status groups. To give a concrete example: among the most educated group (college 
educated in the United States or Austria, upper white collar worker in Finland) we 
find that the United States has excess postneonatal mortality of 0.04 deaths per 1,000 
compared to Finland, and 0.27 deaths per 1,000 compared to Austria. However, 
among the lowest education group, the United States has excess postneonatal mor-
tality of 1.3 deaths relative to Finland, and 1.8 relative to Austria. A similar pattern 
appears across census regions within the United States.
We then take a slightly more parametric approach and define a high socioeco-
nomic status group in each country based on education and other demographic 
characteristics. Infant mortality rates for mothers in our advantaged group are sta-
tistically indistinguishable in the United States and elsewhere. However, there are 
very large differences across countries in infant mortality rates for mothers outside 
of this group. We see similar patterns across census regions within the United States. 
Effectively, either across countries or across regions within the United States, we see 
that the observed geographic variation in postneonatal mortality is heavily driven 
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Figure 1. Cumulative Probability of Death, by Country
notes: This figure shows the cumulative probability of death, by country and timing of death, 
unconditional on conditions at birth. Data for all countries cover 2000–2005; as described in 
the text, the sample is limited to singleton births at  ≥ 22 weeks of gestation and  ≥ 500 grams 
with both birth weight and gestational age observed.
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by variation in health gradients across socioeconomic groups.3 Notably, when we 
look at neonatal mortality we do not draw the same conclusions, suggesting that the 
inequalities we observe emerge especially strongly during the postneonatal period.
The final question we investigate is to what extent the differences in postneonatal 
mortality gradients by location reflect differences in resource gradients. That is, are 
the poor more resource-poor in some regions than others, or is it that the relationship 
between resources and mortality differs across locations? We address this question 
as follows. Although data availability constraints prevent us from linking individu-
als in our birth data to their household income, we link individuals to a measure of 
the average income in their geographic area for individuals with their demographic 
profile (age, education, race, marital status). We are able to do this for the United 
States and Finland, in both cases using census data.4 We use these linked data to 
divide births into income decile groups, and compare across countries or across 
regions within a group. Our analysis suggests that income per se explains very little 
of the difference either between the United States and Finland, or across regions 
within the United States. It is true, for example, that high postneonatal mortality 
regions in the United States are also those with lower income on average. However, 
infants in these regions are more likely to die during the postneonatal period even 
compared to households with similar income levels in regions with lower mortality. 
Our decomposition suggests that income differences actually exacerbate the IMR 
gap between the United States and Finland (since the United States is on average 
richer), and explain only about 30 percent of the differences across areas in the 
United States.
This paper relates to two earlier literatures, one in medicine and one in econom-
ics. In the medical literature, most analyses have focused on differences in health 
at birth as the key explanation for the US IMR disadvantage (MacDorman and 
Mathews 2009, National Research Council 2013, Wilcox et al. 1995). As we note 
above, our data suggest this explanation is incomplete and that excess postneonatal 
mortality may be equally important. Consistent with that finding, Kleinman and 
Kiely (1990) document that the United States had a disadvantage in aggregate post-
neonatal mortality during the 1980s. This suggests that the disparities in postneo-
natal mortality we document are long-standing, although those authors did not have 
access to international microdata, which limits their ability to analyze comparably 
reported samples.
In the economics literature, this paper relates closely to the work of Case, 
Lubotsky, and Paxson (2002) who use various US survey datasets to investigate 
3 Given that one of the most striking facts about infant mortality in the United States is the disparity in mortality 
between black and white infants, it is important to note that the facts we document in this paper are essentially 
unchanged if we exclude US blacks from the sample. The literature investigating the black-white IMR gap has 
generally concluded that differential health at birth can account for the vast majority of the black-white gap, and that 
differences in postneonatal mortality are both less important and can be accounted for by differences in background 
characteristics (Miller 2003; Elder, Goddeeris, and Haider 2011). In contrast, our findings suggest that differences 
in postneonatal mortality account for as much or more of the US IMR disadvantage relative to Europe than do 
differences in health at birth, and that these differences in postneonatal mortality are not eliminated by conditioning 
on a set of (albeit, limited) background characteristics. Taken together, the prior literature and our analysis thus 
suggest that the mechanisms explaining the black-white IMR gap within the United States may be different from 
the mechanisms explaining the US IMR disadvantage relative to Europe. 
4 Unfortunately, similar data for Austria are not easily available. 
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the changing relationship between health status and family income as children age 
(examining age ranges starting at 0–3 and ending at 13–17). They document that 
health erodes more quickly with age for children from lower socioeconomic status 
families; as in our study, this fact is not altered by conditioning on measures of 
health at birth. Currie and Stabile (2003) document a similar finding in Canadian 
survey data, as do Case, Lee, and Paxson (2008) (revisiting an earlier analysis by 
Currie, Shields, and Price 2007) in UK data.5 Our analysis suggests that the health 
gradient in the United States largely emerges after the first month of life, which 
accords with Case and coauthors’ conclusion that the gradient increases with age 
in the United States. However, our data from Europe provide stark evidence that no 
similar gradient emerges during the first year of life in those countries.
In terms of policy implications, these new facts together suggest that a sole focus 
on improving health at birth (for example, through expanding access to prenatal 
care) will be incomplete, and that policies which target disadvantaged groups during 
the postneonatal period may be a productive avenue for reducing infant mortality 
in the United States. Further, our income evidence suggests that simply increasing 
resources may not be sufficient to achieve this goal. As we discuss more in the 
conclusion, one policy lever deserving of future research attention is home nurse 
visiting programs, which have been shown to reduce postneonatal mortality rates in 
randomized trials (Olds et al. 2007).
I. Data
A. Data Description
Birth, Death, and Demographic Data.—Our cross-country analysis relies on two 
types of data. For the United States, Austria, and Finland, we have access to micro-
data. The US data come from the National Center for Health Statistics (NCHS) birth 
cohort linked birth and infant death files. Austrian data are provided by Statistics 
Austria, and Finnish data are extracted from the Finland Birth Registry and Statistics 
Finland. As in prior research that has focused on comparing the mortality outcomes 
of US infants with infants from Scandinavian countries such as Norway (Wilcox 
et al. 1995), Finland provides a sense of “frontier” infant mortality rates. We chose 
Austria as a second point of comparison because of the availability of microdata. 
Notably, over the time period of our study, Austria’s IMR is similar to much of con-
tinental Europe.
The data for each of these three countries consists of a complete census of births 
from years 2000–2005, linked to infant deaths occurring within one year of birth.6 
While birth and death certificates in the United States and Finnish data are centrally 
linked, we link the Austrian records using a unique identifier constructed from the 
36  variables common to both the birth and death records.7 Each country’s birth 
5 A broader literature has examined the relationship between health and socioeconomic status at older ages, such 
as Ford et al. (1994) and Power and Matthews (1997). 
6 The years 2000–2005 are the most recent available years with full data from all three countries from which we 
were able to obtain microdata. 
7 All deaths are matched to a unique birth in the data. 
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records provide information on a rich set of covariates, including the infant’s con-
ditions at birth (such as birth weight and gestational age), and some information 
on demographics of the mother. For infants who die within one year of birth, we 
observe age and cause of death.8 We exclude from our analyses observations which 
are missing data on birth weight or gestational age (1.0 percent in the United States, 
none in Austria, 0.4 percent in Finland). For the analysis of variation by socio-
economic status, we exclude observations which are missing any of our socioeco-
nomic status covariates (2.2 percent in United States, none in Austria, 10.9 percent 
in Finland). The higher share in Finland is primarily due to missing occupation data.
To complement this three-country comparison, we use the best available—albeit 
more aggregated—data from two additional countries: the United Kingdom and 
Belgium. It is possible to do the core of our analysis with somewhat aggregated 
data: we require that the data be limited to our comparable sample (as discussed 
in Section IIA, this is singleton births at or after 22 weeks of gestation and at least 
500 grams in birth weight), and that birth and death counts be reported by 500 gram 
birth weight bins and detailed ages at death.
Data from the United Kingdom were generated through a special request to the 
UK Office of National Statistics. They limited the data to singleton births, at or 
after 22 weeks of gestation and at least 500 grams in birth weight and provided us 
with data on births by 500 gram bins matched to deaths at less than 1 day, 1 day to 
1 week, 1 week to 1 month, 1 to 3 months, 3 to 6 months, and 6 to 12 months. The 
birth weight cells are capped at 4,000 grams.
Data for Belgium were downloaded from online records through the Centre for 
Operational Research in Public Health. Data are provided in 100 gram bins with 
counts of births and deaths and the ability to limit to singleton births. Belgian report-
ing standards limit the data to gestational ages of at or after 22 weeks, and the 
birth weight cells allow us to restrict attention to births at least 500 grams in birth 
weight. Information is provided on deaths in the first week, 1 week to 1 month, 1 to 
6 months, and 6 to 12 months.
For the within-US analysis we use the same NCHS linked files described above. 
These analyses use data from 2000 through 2003; the 2004 and 2005 NCHS data do 
not report sufficient geographic detail to be useful for this analysis.9
Income Data.—In Section IV, we present analyses that rely on having some mea-
sure of household income matched to the birth data. Unfortunately, it is not possible 
to directly match household income to the natality files in the United States, or in 
any of the European countries. As an alternative, we match to income measures 
8 To code cause of death as consistently as possible across years, we use the NCHS General Equivalence 
Mappings (GEMs) to cross-walk across ICD9 and ICD10 codes. After converting all ICD9 codes to ICD10 codes, 
we use the NCHS recode of the ICD10—specified in the NCHS birth cohort linked birth and infant death docu-
mentation—to consistently code causes of death across all countries and all years. The GEM files are available 
here: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Publications/ICD10CM/2010/2010_DiagnosisGEMs.zip. For 
Austria, causes of death prior to 2002 are ICD9 codes, and from 2002–2005 are ICD10 codes. For Finland, causes 
of death are ICD10 codes. For the United States, the original cause of death variable is the NCHS ICD10 recode. A 
handful of observations have multiple matches from the ICD9 coding to the NCHS ICD10 recode; for these obser-
vations, we randomly select one NCHS recode value from the set of possible matches. 
9 Specifically, the 2004 and 2005 data do not report state or county so we cannot use them for the income anal-
ysis. Rather than changing samples, we simply exclude these years from the main analysis as well. 
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based on subnational geographic groups crossed with demographics. We are able to 
do this for Finland and for the United States; the data for the United States can be 
used to extend the income analysis to within-US cross-region comparisons.
For the United States, we use income data from the Integrated Public Use 
Microdata Series (IPUMS) combined for 2000 and 2005. We generate measures of 
median income for bins defined by the following characteristics of the mother: pub-
lic use microdata area (PUMA), ten year age groups (< 30, 31–40, 41–50, over 50), 
education (less than high school, high school degree, some college, college degree 
or more), marital status (married or not), and race. We link PUMAs to counties 
using a crosswalk, since county is reported in the NCHS files. In some cases, the 
NCHS files do not report county (small counties within a state are jointly reported). 
In these cases, we create a “residual” geography for each state that aggregates the 
median income for PUMAs associated with counties that are not reported individ-
ually in the NCHS files. We collapse the IPUMS data to these geographic-demo-
graphic cells and merge with the NCHS data at the cell level. For the within-US 
comparisons we collapse to median income. When we compare the United States to 
Finland, we collapse to median income, adjusted to after-tax income for the United 
States using the NBER TaxSim algorithm for comparability with our Finnish data 
(which reports after-tax income).
For Finland, we use data for 2000 through 2005 provided by Statistics Finland 
based on their household budget survey. The data are provided in summary cells of 
mothers’ characteristics: region, education (basic, upper secondary and lower ter-
tiary, undergraduate or more), ten year age groups, and marital status. The income 
measure provided is median after-tax income. We merge these data with the Finnish 
birth data, matching the three education bins to the three occupation bins available 
in the Finnish birth data.
B. Summary Statistics
Summary statistics are shown in Table 1 for our cross-country data and Table 
2 for our cross-census division data. As expected, Table 1 documents that the 
United States has the highest mortality among the countries considered. Panel A 
reports mortality, gestation (for Finland, Austria, and the United States), and birth 
weight in our restricted sample of singleton births at least 22 weeks of gestation 
and weighing at least 500 grams (this sample restriction is discussed in more detail 
in Section IIA). This sample restriction lowers the death rates in all five countries. 
In terms of birth weight, arguably the most reliable estimate of conditions at birth 
(Dietz et al. 2007), the United States looks similar to Austria, the United Kingdom, 
and Belgium. Finland has much higher average birth weight than any of the other 
countries, with infants an average of 200 grams heavier than elsewhere.
In panel B, we focus on the subsample for which we observe demographics and 
provide summary statistics on demographic covariates (available only for the United 
States, Austria, and Finland). This further sample restriction does not substantially 
change death rates, birth weight, or gestational age. Mother’s age is lowest in the 
United States at 27 years, and closer to 29 years in Austria and Finland. Fifteen 
percent of births in the United States are to black mothers; race is reported only 
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in the United States. The share of births to married women is approximately 60 to 
65  percent in all three countries. Twenty-six percent of women in the United States 
have a college degree or more, versus 12 percent in Austria. For Finland, we observe 
only occupation rank: we consider “upper white collar” workers as the highest 
socioeconomic status group; they make up 22 percent of the sample.
Table 2 shows the same summary statistics across census divisions within the 
United States. There is wide variation in death rates, birth weight, and demographics 
across divisions. The Northeast has the lowest mortality rates and the highest birth 
weights.
II. Results: United States versus Europe
Our accounting exercise investigates four potential sources of the US IMR dis-
advantage: reporting, birth weight, neonatal mortality, and postneonatal mortality.
A. reporting Differences
A well-known issue with cross-country comparisons of infant mortality is 
possible reporting differences for infants born near the threshold of viability. 
Extremely preterm births recorded as a live birth in some places may be considered 
Table 1—Cross-Country Summary Statistics
  United 
States Austria Finland
United 
Kingdom* Belgium*
(1) (2) (3) (4) (5)
Death within 1 year, per 1,000 births, full sample 6.78 3.98 3.21 5.33 4.40
Number of births 24,484,028 466,227 339,312
Panel A. main sample
Death within 1 year, per 1,000 births, restricted sample 4.65 2.94 2.64 3.43 3.67
Gestational age (weeks) 38.8 38.6 39.4
Birth weight (grams) 3,332 3,345 3,550 3,368 3,310
Number of births 23,411,153 451,920 327,732 3,942,209 667,697
 
Panel B. Demographic sample
Death within 1 year, per 1,000 births, restricted sample 4.55 2.94 2.63
Gestational age (weeks) 38.8 38.6 39.4
Birth weight (grams) 3,333 3,345 3,553
Male infant (%) 51.2% 51.2% 51.3%
Mother’s age (years) 27.40 28.75 29.51
Mother is black [US] or immigrant [AU] (%) 14.9% 23.9% —
Mother is married (%) 65.3% 65.3% 59.9%
Mother has at least college degree (%) 25.7% 11.9%
Mother is “upper white collar” worker (%) 21.8%
Number of births 23,113,240 451,920 292,786
notes: Race is reported only in the US data. Data cover 2000 through 2005. The first row contains the full (unad-
justed) sample. Panel A is limited to singleton births at  ≥ 22 weeks of gestation and  ≥ 500 grams with birth weight 
and gestational age observed. Panel B limits to observations with no missing demographic covariates. 
* For the United Kingdom and Belgium, the unadjusted death rates come directly from the World Development 
Indicators database; gestational age and demographic data are not available in the tabulations we obtained for these 
countries.
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miscarriages or stillbirths in other countries (Golding 2001, Graafmans et al. 
2001, Sachs et al. 1995, Wegman 1996). Since survival before 22 weeks or under 
500 grams is very rare, categorizing these births as live births would inflate reported 
infant mortality rates (which are reported as a share of live births).
Table 2—Cross-Census Division Summary Statistics
Northeast
Mid-
Atlantic
East 
North 
Central
West 
North 
Central
South 
Atlantic
(1) (2) (3) (4) (5)
Death within 1 year, per 1,000 births, full sample 5.27 6.36 7.60 6.66 7.96
Number of births 689,261 2,052,697 2,472,299 1,074,249 2,917,487
Panel A. main sample
Death within 1 year, per 1,000 births, restricted sample 3.16 4.15 5.06 4.68 5.29
Gestational age (weeks) 39.0 38.9 38.9 38.9 38.8
Birth weight (grams) 3,402 3,349 3,355 3,386 3,309
Number of births 657,149 1,968,975 2,380,996 1,034,506 2,814,862
Panel B. Demographic sample
Death within 1 year, per 1,000 births, restricted sample 3.08 3.95 4.98 4.61 5.15
Gestational age (weeks) 39.0 39.0 38.9 38.9 38.8
Birth weight (grams) 3,403 3,351 3,356 3,387 3,310
Male infant (%) 51.3% 51.2% 51.2% 51.2% 51.1%
Mother’s age (years) 33.78 32.29 32.27 32.39 32.27
Mother is black [US] or immigrant [AU] (%) 8.8% 18.1% 15.1% 8.0% 26.3%
Mother is married (%) 71.2% 66.1% 65.4% 69.5% 63.4%
Mother has at least college degree (%) 38.8% 30.4% 26.5% 29.6% 25.9%
Number of births 651,851 1,799,490 2,354,809 1,025,991 2,787,062
           
  East 
South 
Central
West 
South 
Central Mountain Pacific
(6) (7) (8) (9)
Death within 1 year, per 1,000 births, full sample 8.85 6.60 6.09 5.37
Number of births 953,341 2,107,572 1,204,992 2,747,287
         
Panel A. main sample
Death within 1 year, per 1,000 births, restricted sample 6.30 4.90 4.47 3.78
Gestational age (weeks) 38.6 38.7 38.8 39.0
Birth weight (grams) 3,277 3,303 3,304 3,389
Number of births 919,404 2,033,140 1,167,269 2,532,336
Panel B. Demographic sample
Death within 1 year, per 1,000 births, restricted sample 6.26 4.83 4.35 3.68
Gestational age (weeks) 38.6 38.7 38.8 39.0
Birth weight (grams) 3,277 3,304 3,305 3,389
Male infant (%) 51.2% 51.1% 51.2% 51.2%
Mother’s age (years) 31.18 31.49 32.06 32.32
Mother is black [US] or immigrant [AU] (%) 24.9% 15.1% 3.1% 5.5%
Mother is married (%) 63.2% 65.4% 68.2% 68.1%
Mother has at least college degree (%) 20.3% 18.9% 21.7% 23.3%
Number of births 917,058 2,007,779 1,145,742 2,405,124
notes: Race is reported only in the US data. Data cover 2000 through 2003. The first two rows summarize data for 
the full (unadjusted) sample. Panel A is limited to singleton births at  ≥ 22 weeks of gestation and  ≥ 500 grams with 
birth weight and gestational age observed. Panel B limits to observations with no missing demographic covariates.
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Past literature (notably MacDorman and Mathews 2009) has addressed this con-
cern by limiting the sample to infants born after 22 weeks of gestation. Although 
previous literature has largely focused on the fact that this restriction does not sub-
stantially change the rank of the US IMR relative to other countries, it is nonetheless 
quite quantitatively important. This can be seen by comparing the first and second 
bars for Austria and Finland in Figure 2. The first bar shows the excess deaths in the 
United States relative to other countries in the full sample. The second bar limits to 
infants born at or after 22 weeks of gestation. The US disadvantage declines once 
we impose this additional restriction.
Our data allow us to address two related issues, which prior literature has not 
explored. First, many countries also have reporting requirements related to birth 
weight and may not report infants under 500 grams as live births (MacDorman 
and Mathews 2009). Second, the presence of assisted reproductive technologies 
has increased the frequency of multiple births, which have higher mortality rates. 
Because the use of assisted reproductive technologies is a choice that we need not 
aim to fix via changes in policy or behavior, it seems appropriate to limit the sample 
to singleton births. The third column within each country in Figure 2 adds both of 
these sample restrictions. Adding these restrictions we are also able to look at the 
comparison with the United Kingdom and Belgium.
The US disadvantage shrinks further with these additional restrictions. Overall, 
limiting to a sample of singleton births at birth weights and gestational ages where 
reporting is not a concern reduces the excess US infant mortality in both magnitude 
and share terms. In the unrestricted samples, the US excess mortality ranges from 
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Figure 2. US IMR Disadvantage: Full Sample and Restricted Samples
notes: This figure shows the number of excess US deaths per 1,000 births compared to Austria 
and Finland overall (the first set of bars), in the sample restricted to births  ≥ 22 weeks of ges-
tation (second set of bars), and in the sample restricted to singleton births  ≥ 22 weeks of ges-
tation and  ≥ 500 grams (third set of bars). For the United Kingdom and Belgium the first set 
of bars come directly from the World Development Indicators database; the second set of bars 
cannot be calculated for these countries because gestational age data are not available in the 
tabulations we obtained for these countries.
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1.4 to 3.6 deaths per 1,000, or between a 27 percent and a 110 percent increase in 
death rates relative to the European baseline. In the restricted sample, the  magnitude 
range is 1.1 to 2.1 excess deaths per 1,000 births, or between a 27 percent to 76 per-
cent increase. However, even in this restricted sample there is significant excess 
mortality in the United States.
B. conditions at Birth
In contrast to the dismissal of reporting differences as a complete explanation, 
past literature has argued that high preterm birth rates in the United States are the 
major contributor to higher infant mortality rates (MacDorman and Mathews 2009, 
Wilcox et al. 1995). This literature has generally compared the United States to 
Scandinavian countries, which have among the lowest infant mortality rates in 
Europe, and has generally focused on gestational age (which is more readily avail-
able in aggregate datasets) rather than birth weight. Our data are able to expand 
this previous literature in two ways. First, it incorporates comparisons with Austria, 
the United Kingdom, and Belgium, which are more representative of the European 
distribution but still much better off than the United States. Second, we add com-
parisons based on birth weight, which is typically more precisely measured than 
gestational age (Dietz et al. 2007).
As noted in the summary statistics, in our comparably-reported sample, birth 
weight (and gestational age) in the United States is worse than in Finland but close 
to the other countries considered. For the three countries with microdata, Appendix 
Figures A1, panels A and B show the full distribution of birth weight and gestational 
age. Similar to our observation based on the means, the most striking feature of 
these distributions is the difference between Finland and either the United States or 
Austria.10
To be more concrete, we consider how the US disadvantage relative to the com-
parison countries changes once we adjust for birth weight; this is done by comparing 
columns 1 and 2 of Table 3. Each panel of this table compares the United States to 
each European country in our data separately. The first column estimates regressions 
which limit to the comparable sample but include no covariates, only an indicator 
variable for the United States. The coefficients therefore represent the baseline dif-
ference in infant mortality between the United States and the other countries consid-
ered. In column 2 of each panel, we add birth weight controls (specifically, indicator 
variables for 500 gram birth weight bins). The coefficient in this column therefore 
represents the US infant mortality disadvantage once we adjust flexibly for birth 
weight. Conceptually, this follows the previous literature by calculating the excess 
mortality in the United States if the birth weight distribution were the same as in 
Europe (MacDorman and Mathews 2009). Relative to this existing literature, we 
adjust more precisely with birth weight bins rather than just indicators for normal 
or low birth weight (or indicators for preterm versus full term). The reduction in the 
10 Although the United States and Austria look almost identical in this figure, in fact Austria has a slightly more 
favorable birth weight distribution. This is driven by differences in the two countries in the lowest birth weight 
categories—under 1,000 grams—which are too small to see in the distribution but matter for survival. 
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Table 3—Cross-Country Differences in Mortality
Sample, controls:
Comparable 
sample, 
no 
controls
Comparable 
sample, 
birth weight 
controls
Comparable 
sample, 
birth weight 
controls
Comparable 
sample, 
birth weight 
controls
Comparable 
sample, 
birth weight 
controls
Mortality (in 1,000s):
First 
year
(1)
First 
year
(2)
< 1 week
(3)
1 week to 
1 month
(4)
1 to 
12 months
(5)
Panel A. United States versus Finland
United States 2.008*** 0.533*** −0.276*** 0.164*** 0.647***
(0.091) (0.088) (0.063) (0.033) (0.054)
Cumulative effect, United States −0.276 −0.112 0.535
Observations 23,738,885 23,738,885 23,738,885 23,695,461 23,677,125
Finland mortality level 1.352 0.351 0.938
Cumulative mortality, Finland 1.352 1.703 2.641
Panel B. United States versus Austria
United States 1.704*** 1.140*** −0.019 0.068* 1.083***
(0.082) (0.077) (0.056) (0.036) (0.043)
Cumulative effect, United States −0.019 0.049 1.132
Observations 23,863,073 23,863,073 23,863,073 23,819,403 23,800,909
Austria mortality level 1.525 0.605 0.816
Cumulative mortality, Austria 1.525 2.130 2.943
Panel c. United States versus United Kingdom
United States 1.214*** 0.781*** 0.043** 0.091*** 0.648***
(0.033) (0.031) (0.021) (0.014) (0.020)
Cumulative effect, United States 0.043 0.134 0.782
Observations 27,353,362 27,353,362 27,353,362 27,304,313 27,283,696
UK mortality level 1.539 0.609 1.289
Cumulative mortality, United Kingdom 1.539 2.148 3.437
Panel D. United States versus Belgium
United States 0.983*** 0.252*** −0.264*** 0.042 0.458***
(0.075) (0.072) (0.048) (0.030) (0.047)
Cumulative effect, United States −0.264 −0.222 0.236
Observations 24,078,850 24,078,850 24,078,850 24,034,786 24,016,169
Belgian mortality level 1.622 0.594 1.453
Cumulative mortality, Belgium 1.622 2.216 3.669
notes: This table shows differences across countries in mortality, using Finland (panel A), Austria (panel B), the 
United Kingdom (panel C), or Belgium (panel D) as the omitted country. Columns 1 and 2 analyze overall  one-year 
mortality. Column 1 limits to the comparable sample but includes no controls. Column 2 adjusts for 500 gram birth 
weight category cells. Columns 3 through 5 include birth weight controls and look at deaths in various periods of 
life. The regression results in these columns are conditional on reaching the minimum age: deaths up to one week; 
deaths from one week to one month, conditional on surviving to one week, etc. Coefficients are in units of 1,000 
deaths: a coefficient of 1 indicates an increase of 1 death in 1,000 births. For columns 3 through 5, each panel also 
shows the cumulative effect by country (the sum of the coefficients up to that point). Robust standard errors are 
in parentheses. Data for all countries cover 2000–2005; as described in the text, the sample is limited to singleton 
births at  ≥ 22 weeks of gestation and  ≥ 500 grams with birth weight and gestational age observed.
*** Significant at the 1 percent level.
 ** Significant at the 5 percent level.
  * Significant at the 10 percent level.
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coefficient moving from column 1 to column 2 in each panel tells us the share of the 
mortality difference across countries, which is accounted for by birth weight.
The importance of birth weight varies across the comparison country. Birth weight 
accounts for about 75 percent of the gap between the United States and Finland 
(panel A of Table 3) or between the United States and Belgium (panel D of Table 3). 
However, it only accounts for about 30 percent of the gap between the United States 
and Austria or the United Kingdom. This evidence confirms existing arguments that 
birth weight matters for the US infant mortality disadvantage, although it suggests 
that the prior literature’s focus on Scandinavian countries may have overstated the 
importance of this explanation.
Even without this calibration, simple summary statistics make it clear that the 
conditions-at-birth explanation is incomplete. Among normal birth weight infants in 
the United States, the infant mortality rate is 2.3 deaths per 1,000 births, versus just 
1.3 for Austria, 1.5 for Finland, 1.6 for the United Kingdom, and 2.0 for Belgium.
C. Timing of the US Imr Disadvantage: neonatal and Postneonatal mortality
We turn now to examine the timing of the US IMR disadvantage. It is here that the 
value of having disaggregated data—ideally, microdata—becomes even clearer. The 
previous literature has been unable to compare mortality timing within the first year 
across countries in nonaggregate data, which is crucial in light of the reporting dif-
ferences highlighted above. In unrestricted 2005 data from the World Development 
Indicators, neonatal mortality in the European countries considered varied from 2.1 
per 1,000 live births (Finland) to 3.5 (the United Kingdom), whereas the United 
States reports a neonatal mortality rate of 4.5 (World Bank 2013). Postneonatal mor-
tality differs less in this sample: 2.3 per 1,000 live births in the United States, versus 
a range of 1.3 to 2.0 in the European countries. However, differences in reporting 
could be an important driver of these trends—particularly for neonatal mortality—
and from a policy perspective it is also important to understand whether these differ-
ences persist when comparing across infants with the same measured health at birth.
For the three countries with detailed microdata, it is possible to show evidence on 
the timing of the US IMR disadvantage graphically. Figures 1 and 3 document the 
cumulative probability of death by age by country.11 In the full comparably-reported 
sample (Figure 1) the US 1-day IMR (in deaths per 1,000 live births) is 0.23 higher 
than Austria and 0.40 higher than Finland. Within the first week these differences 
increase only slightly—to 0.31 and 0.48. However, between 1 month and 1 year 
these differences accelerate: the differences at 1 year are 1.70 and 2.00 for the com-
parisons with Austria and Finland, respectively.
This postneonatal mortality disadvantage is even more striking in Figure 3, which 
graphs the cumulative probability of death over the first year separately for nor-
mal ( ≥ 2,500 grams) and low (< 2,500 grams) birth weight infants. As expected, 
within each group mortality rates at one year in the United States are higher than in 
11 It is not possible to add the United Kingdom or Belgium to these graphs since the data on timing are not as 
fine. We will be able to use data from these countries in the tables when we aggregate to the first week, 1 week to 
1 month, and 1 to 12 months. 
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Austria and Finland. Figure 3, panel A clearly suggests that the US IMR disadvan-
tage arises in the postneonatal period: the United States has virtually identical mor-
tality rates to Austria and Finland up to one month, and then much higher mortality 
after one month. The pattern of mortality differences among low birth weight infants 
in Figure 3, panel B looks very similar to Figure 3, panel A, the only difference being 
that the United States actually seems to have lower mortality than Finland during the 
first month of life.
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Figure 3. Cumulative Probability of Death, by Country, by Birth Weight
notes: These figures show the cumulative probability of death, by country, timing of death, 
and birth weight. In panel A, the sample includes normal birth weight babies ( ≥ 2,500 grams). 
In panel B, the sample includes low birth weight babies (2,500 grams). Data for all coun-
tries cover 2000–2005; as described in the text, the sample is limited to singleton births at 
 ≥ 22 weeks of gestation and  ≥ 500 grams with both birth weight and gestational age observed. 
In total, 94.1 percent of births are in the normal birth weight category shown in panel A, and 
5.9 percent are in the low birth weight category in panel B.
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Columns 3 through 5 of Table 3 quantify the patterns in these figures, and 
adds analyses of the UK data and Belgium data. In these estimates we focus on 
cross-country differences in marginal (noncumulative) death rates at various ages 
over the first year, and condition on detailed measures of birth weight (as in column 
2, we use 500 grams bins).12
We estimate impacts in three timing bins: < 1 week, 1 week to 1 month, and 
1–12 months. The United States has, on average, a mortality advantage in the ear-
liest period. Over the first week of life, the United States has significantly lower 
mortality rates than Finland or Belgium, and is roughly even with Austria and the 
United Kingdom. The first-week differences with respect to Finland and Belgium 
are reasonably large: a survival advantage of 0.3 deaths per 1,000 births in the 
United States. However, in the postneonatal period (from one month to one year) 
the United States has a significant disadvantage relative to any of the comparison 
countries. The excess mortality in this period ranges from 0.45 deaths per 1,000 
(relative to Belgium) to 1.1 deaths per 1,000 (relative to Austria). This postneonatal 
period explains between 30 and 65 percent of the overall US IMR disadvantage (i.e., 
as shown in column 1), comparable on average to the importance of birth weight.
There are of course a number of open questions about these timing of death 
results, some of which we can address with the microdata from Finland and Austria. 
Appendix Table A1 documents a series of robustness checks. The pattern we 
observe is not driven by very small infants: in Appendix Table A1 (row 2) we show 
similar patterns if we exclude births less than 1,000 grams. These patterns are also 
not driven by differences in average demographics across the three countries: in 
Appendix Table A1 (row 3), we replicate these regressions controlling for maternal 
age, child sex, and maternal demographics, with identical conclusions.
One possible theory is that the observed elevation in postneonatal mortality is driven 
by a delay of deaths in the United States. If hospitals in the United States are better at 
keeping very low birth weight newborns alive for a slightly longer period of time, this 
could show up in the data as low neonatal mortality and excess postneonatal mortality. 
It is clear from the fact that we see elevated US infant mortality at one year that this is 
not a complete explanation. In addition, this type of substitution will be less important 
among groups which have low rates of neonatal mortality, such as normal birth weight 
infants or infants with a high Apgar score. Yet these groups also have much elevated 
postneonatal mortality, as can be seen in Figure 3 for normal birth weight infants, and 
row 4 of Appendix Table A1 for infants with Apgar scores of 9 or 10. This suggests 
that this concern is unlikely to be quantitatively important.
The next section will focus on decomposing these results by demographic group, 
but it is important to note that our estimates are not driven by the mortality out-
comes of black infants (who have long been observed to have relatively poor birth 
 outcomes in the United States): Appendix Table A1 (row 5) excludes blacks from 
our US sample, and a similar postneonatal disadvantage is still evident.13
12 Replacing the 500 gram birth weight bins with 100 gram birth weight bins yields virtually identical results. 
13 An additional possibility is that the results could be driven by first births, if first-time mothers are less 
informed about appropriate care for newborns. The data suggest this explanation does not account for the patterns 
in the data: Appendix Table A1 (row 6) excludes first births, and the resulting estimates are quite similar. Finally, 
row 7 of Appendix Table A1 adds multiple births back into the sample, with again very similar results. 
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Relative to the average death rates, the US disadvantage in the postneonatal period 
is very large. Over the period from 1 to 12 months, the death rate in Austria was 0.81 
per 1,000. Based on the coefficients, the predicted death rate in the United States 
given the same birth weight distribution would be 1.89 per 1,000 births, more than 
twice as large. This is especially striking since Austria is very close to the United 
States on birth weight distribution (see Appendix Figure A1, panel B) and also quite 
similar on neonatal mortality. Effectively, despite starting with very similar birth 
weight and very similar neonatal mortality outcomes, Austria vastly outpaces the 
United States starting at one month of age.
Together, this evidence suggests that aggregate comparisons are misleading. 
Whereas in the aggregate data the US disadvantage appears to be more important 
during the neonatal period than during the postneonatal period, in fact the opposite 
appears to be true.
D. causes of Death
A natural question, following on the results above, is which causes of death 
account for the US disadvantage in the postneonatal period. In the Austrian, US, and 
Finnish data we observe cause of death codes. A central issue—difficult to resolve—
is differences in cause of death coding across countries. For example, Austria codes 
many postneonatal deaths as being due to low birth weight; virtually no deaths in 
either the United States or Finland use this code during this time period. In all three 
countries a very large share of deaths—perhaps as much as a third—are in small 
categories which aggregate to “other” but are not very informative on their own. 
Further, because correct coding of sudden infant death syndrome (SIDS) deaths is 
difficult (Kim et al. 2012; Pearson, Ward-Platt, and Kelly 2011) this cause may be 
difficult to interpret.
With these caveats, Table 4 shows postneonatal death rates in six cause of death 
categories. We calculate the postneonatal death rate (per 1,000) for each cause group 
for each country and then calculate the US-Finland difference and the US-Austria dif-
ference. We also calculate the percent increase over the Finnish or Austrian death rate.
These cause of death results are similar for Austria and Finland. In raw difference 
terms SIDS and other sudden deaths are the most important, although this is largely 
because these causes account for the largest number of deaths. Accidents seem to 
play an important role in both raw and share terms. As a share, deaths from assault 
and respiratory infections (largely pneumonia) are much higher in the United States, 
although these represent a small number of deaths. Taken together, there is no clear 
smoking gun from this table.
III. Results: Within-US Evidence
Our analysis thus far suggests that postneonatal mortality plays an important 
role in driving differences between the United States and a number of countries in 
Europe. In this section we ask whether this result is paralleled when we consider 
geographic variation within the United States.
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We begin by noting, based on the summary statistics in Table 2, that there is 
tremendous variation in infant mortality rates across the United States. This is true 
even though the geographic units we consider are census divisions, which are quite 
broad; it would be even more true if we considered state-level or county-level vari-
ation. Considering the comparable sample reported in panel A of Table 2, one-year 
infant mortality in the Northeast is 3.16 deaths per 1,000 live births, whereas in the 
East South Central region (Oklahoma, Arkansas, Louisiana, and Texas) this figure 
is 6.30 per 1,000. Both the Northeast and the Pacific divisions have overall infant 
mortality rates within the distribution of the European countries considered. If the 
Northeast were a country, it would be similar to Austria.
As a first look at the role of timing, we replicate Figures 1 and 3 for the cen-
sus divisions in Figures 4 and 5. As with the cross-country data, it is evident that 
the gaps across divisions grow in the postneonatal period. In the overall sample, if 
we compare the lowest mortality (Northeast) to the highest mortality (East South 
Central) divisions, we find that between one day and one week of life, the differ-
ence in mortality rates only grows by 0.40 deaths per 1,000 births. Between 1 and 
12 months, this difference increases by 2.41 deaths per 1,000 births.
Table 5 replicates Table 3 but with indicator variables for census division rather 
than country. The omitted division is the Northeast. Column 1 estimates the baseline 
differences across divisions and column 2 adds controls for birth weight. Columns 3 
through 5 retain the birth weight controls and estimate effects by timing of death 
within the first year. Similar to the cross-country analysis, we would like to use these 
estimates to make summary statements about the importance of birth weight, and 
the relative importance of the various periods within the first year. To do this, we 
use the coefficient estimates in Table 5 to calculate the share of the  cross-division 
differences, which are explained by various factors. We calculate these shares for 
each division pair, and then average to produce an overall conclusion about the 
importance of each.
Table 4—Postneonatal Cause of Death, by Country
Cause of death:
Congenital 
abnormalities 
and low birth 
weight Respiratory
SIDS 
and other 
sudden 
deaths Accident Assault Other
(1) (2) (3) (4) (5) (6)
United States 0.380 0.068 0.699 0.208 0.064 0.613
Finland 0.325 0.021 0.226 0.044 0.003 0.287
Austria 0.377 0.007 0.185 0.030 0.013 0.175
United States-Finland
Raw difference 0.055 0.047 0.473 0.164 0.061 0.326
As share of Finland 17% 224% 209% 373% 2,033% 114%
United States-Austria
Raw difference 0.003 0.061 0.514 0.178 0.051 0.438
As share of Austria 1% 871% 278% 593% 392% 250%
notes: This table shows the difference in postneonatal mortality from each cause of death across countries. All 
means are computed on the sample of infants alive at one month. Means are in units of 1,000 deaths. Data for all 
countries cover 2000–2005; as described in the text, the sample is limited to singleton births at  ≥ 22 weeks of ges-
tation and  ≥ 500 grams with birth weight and gestational age observed.
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We consider first birth weight, comparing columns 1 and 2 of Table 5. The 
importance of birth weight varies across the division-pairs. For some division-pairs 
controlling for birth weight increases the baseline gap. In others, the gap is in the 
opposite direction once we control for birth weight. As a summary measure, we 
calculate the share of the cross-division variation accounted for by birth weight dif-
ferences for the median division-pair. This figure is 45 percent.
Turning to the timing of deaths in columns 3 through 5, a simple analysis of the 
coefficient magnitudes suggests that the postneonatal period accounts for a larger 
share of differences than the earlier periods; the coefficient magnitudes are much 
larger. By comparing column 2 to columns 3 through 5 we can assess what share of 
the birth-weight adjusted gaps are accounted for by the first week of life, one week 
to one month of life, and the postneonatal period. These figures are shown in the last 
row of Table 5. The first week of life accounts on average for about 17 percent of the 
gap, the period from a week to a month accounts for 16 percent, and the postneona-
tal period accounts for 67 percent. The second-to-last row reports the share of deaths 
that occur in this period in the Northeast census division, as a point of reference. A 
comparison of the two final rows makes clear that the postneonatal period accounts 
for an outsize share of the cross-division gap relative to its importance in the first 
year.
The relative performance of US census divisions is similar across the first year of 
life. That is, unlike the European comparisons, we do not see evidence that the worst 
off areas do better early on. However, similar to the European comparison, we find 
the postneonatal period accounts for an outsize share of the geographic differences. 
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Figure 4. Cumulative Probability of Death, within United States
notes: This figure shows the cumulative probability of death, by US census division and timing 
of death, unconditional on conditions at birth. Data cover 2000 through 2003; as described in 
the text, the sample is limited to singleton births at  ≥ 22 weeks of gestation and  ≥ 500 grams 
with both birth weight and gestational age observed.
108 AmErIcAn EconomIc JoUrnAL: EconomIc PoLIcy mAy 2016
0
1
2
3
D
ea
th
s 
pe
r 
1,
00
0 
liv
e 
bi
rt
hs
One
day
One
week
One
month
Three
months
Six
months
One
year
N.East Mid.Atl. E.N.Cent.
W.N.Cent. S.Atlantic E.S.Cent.
W.S.Cent. Mount. Pacific
One
day
One
week
One
month
Three
months
Six
months
One
year
N.East Mid.Atl. E.N.Cent.
W.N.Cent. S.Atlantic E.S.Cent.
W.S.Cent. Mount. Pacific
non-LBW (≥ 2,500 grams)
Cumulative probability of death
10
20
30
40
50
D
ea
th
s 
pe
r 
1,
00
0 
liv
e 
bi
rt
hs
LBW (< 2,500 grams)
Cumulative probability of death
Panel A. Normal birth weight only (≥ 2,500 grams)
Panel B. Low birth weight only (< 2,500 grams)
Figure 5. Cumulative Probability of Death, within United States, by Birth Weight
notes: These figures show the cumulative probability of death, by US census division, timing 
of death, and birth weight. In panel A, the sample includes normal birth weight babies ( ≥ 2,500 
grams). In panel B, the sample includes low birth weight babies (< 2,500 grams). Data cover 
2000 to 2003; as described in the text, the sample is limited to singleton births at  ≥ 22 weeks 
of gestation and  ≥ 500 grams with both birth weight and gestational age observed.
VoL. 8 no. 2 109CHEN ET AL.: INFANT MORTALITY IN UNITED STATES AND EUROPE
As one summary statistic, lowering the postneonatal mortality rate of all census 
divisions to the level experienced by the best-off division would reduce infant mor-
tality in the United States by 0.75 deaths per 1,000 births.
IV. Demographics of Postneonatal Disadvantage
It is well known that—relative to Europe—the United States has higher inequality 
on many metrics (Bertola and Ichino 1995). Similarly, there is significant variation 
across the United States in the extent of income inequality by region (Frank 2009). 
Given these patterns, a natural question is whether the variation across countries 
and across regions is explained by worse outcomes among relatively disadvantaged 
households in the United States relative to Europe (or in some census divisions 
Table 5—Cross-Census Division Differences in Mortality
Sample, controls:
Comparable 
sample, no 
controls
Comparable 
sample, birth 
weight controls
Comparable 
sample, birth 
weight controls
Comparable sample, 
birth weight  
controls
Comparable 
sample, birth 
weight controls
Mortality 
 (in 1,000s):
First year
(1)
First year
(2)
< 1 week
(3)
1 week to 1 month
(4)
1 to 12 months
(5)
Mid-Atlantic 0.996*** 0.547*** 0.072 0.163*** 0.320***
(0.097) (0.093) (0.058) (0.040) (0.065)
East North Central 1.907*** 1.521*** 0.296*** 0.311*** 0.931***
(0.095) (0.091) (0.056) (0.039) (0.063)
West North Central 1.521*** 1.496*** 0.374*** 0.256*** 0.874***
(0.108) (0.103) (0.064) (0.044) (0.072)
South Atlantic 2.135*** 1.201*** 0.105* 0.272*** 0.831***
(0.093) (0.089) (0.055) (0.038) (0.062)
East South Central 3.146*** 1.926*** 0.092 0.360*** 1.475***
(0.110) (0.105) (0.065) (0.045) (0.073)
West South Central 1.741*** 1.160*** −0.0237 0.256*** 0.920***
(0.097) (0.093) (0.057) (0.040) (0.064)
Mountain 1.313*** 1.240*** 0.315*** 0.294*** 0.653***
(0.105) (0.101) (0.062) (0.043) (0.070)
Pacific 0.621*** 0.870*** 0.198*** 0.215*** 0.467***
(0.094) (0.090) (0.056) (0.039) (0.063)
Observations 15,508,637 15,508,637 15,508,637 15,480,699 15,468,224
Share of total explained 45.3%
Share of deaths, Northeast 45.9% 15.3% 38.8%
Share of birth weight-adjusted explained 17.3% 15.7% 67.1%
notes: This table shows differences across US census divisions in mortality; the omitted division is the Northeast. 
Columns 1 and 2 analyze overall one-year mortality. Column 1 limits to the comparable sample but includes no 
controls. Column 2 adjusts for 500 gram birth weight category cells. Columns 3 through 5 include birth weight con-
trols and look at deaths in various periods of life. The regression results in these columns are conditional on reach-
ing the minimum age: deaths up to one week; deaths from one week to one month, conditional on surviving to one 
week, etc. Coefficients are in units of 1,000 deaths: a coefficient of 1 indicates an increase of 1 death in 1,000 births. 
Shares reported in the final row are calculated based on each census division pair and averaged. Robust standard 
errors are in parentheses. Data for all countries cover 2000–2003; as described in the text, the sample is limited to 
singleton births at  ≥ 22 weeks of gestation and  ≥ 500 grams with birth weight and gestational age observed.
*** Significant at the 1 percent level.
 ** Significant at the 5 percent level.
  * Significant at the 10 percent level.
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 relative to others).14 For example, a key focus of a recent National Research Council 
report was the question of whether even highly advantaged Americans are in worse 
health than their counterparts in peer countries, or whether worse average health out-
comes in the United States only reflect higher levels of health inequality (National 
Research Council 2013).
In this section we focus on the postneonatal period and explore the demographics 
of the variation in this outcome. We first simply document the variation in post-
neonatal mortality across demographic groups, which provides a broad sense of 
which demographic groups are most important in accounting for mortality variation 
across space. We then put somewhat more structure on the question by defining an 
“advantaged” group in each country/region and asking—akin to the question in the 
National Research Council report—whether there is variation across regions even 
among a relatively more advantaged group. As we will see, these estimates suggest 
that disadvantaged groups account for an outsized share of the cross-regional dif-
ferences in postneonatal mortality rates. We then explore the extent to which these 
mortality gaps are a result of differences in resources (i.e., income) across region, as 
opposed to differences which arise after holding income constant.
The cross-country analysis in this section focuses on the United States, Finland, 
and Austria; our data from the United Kingdom and Belgium unfortunately do not 
provide tabulations by socioeconomic status so we are not able to use these data in 
these analyses. In addition, as noted in the data section, our income data are avail-
able only for the United States and Finland. We will therefore document the income 
analysis only comparing the United States and Finland, and within the United States.
A. Postneonatal mortality by Demographic Group
We begin by investigating how postneonatal mortality rates vary by demographic 
group. Figure 6, panel A documents postneonatal death rates by education/socio-
economic status group, for which we observe four groups in the United States and 
Austria and three groups in Finland. In the United States, this is based on education: 
less than a high school degree, a high school degree, some college, and college 
degree or more. In Austria, we also use educational data: compulsory school, 
vocational school, high school with A-levels, and university or teaching college. 
In Finland, the groups are defined based on occupation: blue collar, lower white 
collar, and upper white collar or entrepreneur. The steeper socioeconomic gradient 
observed in postneonatal mortality within the United States is striking relative to 
the socioeconomic gradients observed in Austria or Finland. Notably, the within-US 
gradient is not simply due to high mortality rates in the least educated group; there 
is wide variation across the distribution; in contrast, to the extent that there is any 
inequality by socioeconomic status in Austria or Finland, it appears to be driven by 
the lowest education or occupation group. Similar findings emerge in Figure 6 panel 
B, across regions within the United States.
14 A large literature—see, for example Avendano (2012)—has estimated the cross-country relationship between 
income inequality and infant mortality, tending to find a strong positive cross-sectional correlation that is not always 
robust to alternative specifications (such as country fixed effect models). 
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What this analysis does not directly address is the question of whether there 
are groups in the United States that do as well as comparable groups in Europe. 
That is: do the most advantaged groups in the three countries—or in the nine cen-
sus divisions—look similar? To investigate this question, we focus attention on an 
“advantaged” demographic: mothers who are high education/occupation, married 
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Figure 6. Gradient in Postneonatal Death Rates by Socioeconomic Status and 
Location
notes: These figures show the gradient in postneonatal death rates by socioeconomic status and 
location. In panel A, the sample for all countries cover 2000 through 2005. In panel B, the sam-
ple within the United States cover 2000 through 2003. The sample is limited to singleton births 
at  ≥ 22 weeks of gestation and  ≥ 500 grams with no missing covariates. Because the death 
rates are postneonatal, the sample also excludes infants who died before one month of age.
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and white (United States) or nonimmigrant (Austria).15 We then compare the mor-
tality profile of this group, and the corresponding less advantaged group, across the 
three countries. It is worth noting in this analysis that the comparison with Austria 
is likely to be the most informative because in both the United States and Austria 
we have data on education; in Finland, we use occupation as a proxy for educational 
level, which is likely to be correlated with education but is less comparable.
We show visual evidence on the cross-country/cross-group comparison in 
Figure  7, which shows cumulative death rates in the three countries for the two 
education/occupation groups. In Figure 7 panel A, the advantaged individuals, there 
appears to be virtually no difference in death rates. In contrast, for the lower portion 
of the distribution (Figure 7 panel B) the US death rate is much higher. In the post-
neonatal period the death rate for this group in the United States is 2.4 per 1,000, 
versus 0.83 in Austria and 0.97 in Finland.
We explore this in regression form by estimating regressions analogous to those 
in column 5 of Table 3 but including an interaction between an indicator variable 
for the United States and an indicator variable for our advantaged definition. We 
can then test whether individuals in the advantaged group have higher mortal-
ity in the United States than elsewhere. This estimation is presented in Table 6. 
Panel A considers postneonatal mortality. Relative to both Austria (column 1) and 
Finland (column 2) the main effect of United States is large and positive and the 
interaction is large and negative. The advantaged group in the United States cannot 
be statistically distinguished from the advantaged group in either of the compari-
son countries.16
Although the primary focus in this section is on postneonatal mortality, in panel B 
of Table 6 we demonstrate that the United States does not show excess inequality 
in neonatal mortality. The main effect of the United States in both columns is neg-
ative, indicating that disadvantaged groups in the United States do better than their 
counterparts in Europe conditional on circumstances at birth (this is marginally sig-
nificant for Finland). The interaction effect is small, statistically insignificant, and 
of differing sign across columns.
Table 7 documents an analogous set of estimates across census divisions within 
the United States. Column 1 focuses on postneonatal mortality. The first set of coef-
ficients, which estimate the differences across the advantaged and non-advantaged 
group, suggests large differences across census divisions.17 The negative interaction 
coefficients suggest that these differences shrink considerably (at least relative to 
the Northeast) when we look at the advantaged group. At the bottom of the table we 
provide a summary measure of the average difference across all division-pairs in the 
advantaged and non-advantaged groups. The average difference for the advantaged 
group is 0.17 deaths per 1,000; for the non-advantaged, it is 0.55 per 1,000. Another 
15 This group accounts for 22 percent in the United States, 7 percent in Austria, and 16 percent in Finland. 
16 Appendix Tables A2 and A3 present analogous results after varying the definition of advantaged. Appendix 
Table A2 uses only the education/occupation variable and Table A3 uses education/occupation and married (but 
not race). The results are very similar. In particular, leaving race out of the definition makes virtually no difference, 
reinforcing our earlier argument that our estimates do not appear to be driven by black/white differences in the 
United States. 
17 This analysis uses a linear probability model; results are similar with a probit approach. 
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way to summarize these estimates is to note that the maximum difference among 
the non-advantaged group is 1.6 excess deaths per 1,000 births (East South Central 
versus Northeast), whereas the maximum difference for the advantaged group is 0.4 
deaths per 1,000.
As a comparison, column 2 of this table estimates the same regressions for neo-
natal mortality. As in our comparison with Europe, across US regions we observe 
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Figure 7. Cumulative Probability of Death, by Country, by Socioeconomic Group
notes: These figures show the cumulative probability of death, by country, timing of death, and 
group. “Advantaged” is as defined in the text (mothers who are high education/occupation, 
married and white (United States), or nonimmigrant (Austria)). Data for all countries cover 
2000–2005; as described in the text, the sample is limited to singleton births at  ≥ 22 weeks of 
gestation and  ≥ 500 grams with no missing covariates.
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much less variation in neonatal mortality relative to postneonatal mortality. Perhaps 
more notable, however, is that the neonatal mortality gaps across advantaged and 
non-advantaged groups are virtually identical across census divisions.
Overall, this evidence suggests that the observed higher US postneonatal mor-
tality relative to Europe is due entirely, or almost entirely, to higher mortality 
among disadvantaged groups. Focusing on the cross-country results, well-off 
individuals in all three countries have similar infant mortality rates. Another way 
to state this is in the context of within-country inequality. In both Finland and 
Austria, postneonatal mortality rates are extremely similar across groups with 
varying levels of advantage, either unconditionally or (more starkly) conditional 
on detailed birth weight. In contrast, there is tremendous inequality within the 
United States, with lower socioeconomic status groups experiencing much higher 
postneonatal mortality rates.
Table 6—Cross-Country Differences in Postneonatal  
and Neonatal Mortality, by Group
United States versus 
Austria
United States versus 
Finland
(1) (2)
Panel A. Postneonatal mortality
United States 1.357*** 0.920***
(0.046) (0.064)
Advantaged −0.093 −0.296**
(0.144) (0.129)
United States × advantaged −1.146*** −0.941***
(0.145) (0.130)
Observations 23,505,784 23,347,108
High SES, United States versus Europe 0.126 0.853
Panel B. neonatal mortality
United States 0.024 −0.149*
(0.068) (0.083)
Advantaged −0.259 −0.080
(0.218) (0.192)
United States × advantaged 0.063 −0.116
(0.219) (0.193)
Observations 23,565,160 23,406,026
High SES, United States versus Europe 0.675 0.128
notes: This table shows differences across countries in mortality by advantaged versus disad-
vantaged group. The regressions adjust for 500 gram birth weight category cells. The regres-
sion results in panel A are conditional on surviving to one month of age. “Advantaged” is as 
defined in the text (mothers who are high education/occupation, married and white (in the 
United States) or nonimmigrant (in Austria)). Coefficients are in units of 1,000 deaths: a coef-
ficient of 1 indicates an increase of 1 death in 1,000 births. Robust standard errors are in paren-
theses. Data for all countries cover 2000–2005; as described in the text, the sample is limited to 
singleton births at  ≥ 22 weeks of gestation and  ≥ 500 grams with no missing covariates. The 
last row in each panel reports the p-value from a test for equality between the advantaged group 
in the United States relative to the advantaged group in the comparison country.
*** Significant at the 1 percent level.
 ** Significant at the 5 percent level.
  * Significant at the 10 percent level.
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Table 7—Cross-Census Division Differences  
in Postneonatal and Neonatal Mortality, by Group
Postneonatal Neonatal
Mortality (in 1,000s): 1 to 12 months < 1 month
(1) (2)
Mid-Atlantic 0.336*** 0.218***
(0.072) (0.084)
Mid-Atlantic × advantaged −0.341*** −0.245*
(0.094) (0.147)
East North Central 1.068*** 0.635***
(0.072) (0.082)
East North Central × advantaged −0.836*** −0.154
(0.095) (0.143)
West North Central 1.021*** 0.642***
(0.085) (0.092)
West North Central × advantaged −0.706*** −0.038
(0.112) (0.162)
South Atlantic 0.912*** 0.335***
(0.070) (0.080)
South Atlantic × advantaged −0.759*** −0.0102
(0.093) (0.141)
East South Central 1.589*** 0.497***
(0.091) (0.092)
East South Central × advantaged −1.229*** −0.067
(0.130) (0.180)
West South Central 0.920*** 0.239***
(0.073) (0.082)
West South Central × advantaged −0.613*** 0.008 
(0.102) (0.152)
Mountain 0.673*** 0.592***
(0.079) (0.089)
Mountain × advantaged −0.604*** −0.163
(0.109) (0.165)
Pacific 0.440*** 0.393***
(0.069) (0.081)
Pacific × advantaged −0.303*** −0.127
(0.093) (0.144)
Advantaged −0.645*** −0.064
(0.078) (0.123)
Observations 15,056,924 15,094,906
Average difference, advantaged 0.17 0.25
Average difference, not advantaged 0.55 0.26
notes: This table shows differences across census divisions in mortality by advantaged ver-
sus disadvantaged group. The regressions adjust for 500 gram birth weight category cells. The 
regression results in column 1 are conditional on surviving to 1 month of age. “Advantaged” 
is as defined in the text (mothers who are high education/occupation, married, and white). 
Coefficients are in units of 1,000 deaths: a coefficient of 1 indicates an increase of 1 death in 
1,000 births. Robust standard errors are in parentheses. Data cover 2000–2003; as described in 
the text, the sample is limited to singleton births at  ≥ 22 weeks of gestation and  ≥ 500 grams 
with no missing covariates.
*** Significant at the 1 percent level.
 ** Significant at the 5 percent level.
  * Significant at the 10 percent level.
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B. The role of Income Differences
One explanation for the excess variation across groups in the United States 
(or within the poorer census divisions) is excess variation in income. Income per 
se has been shown to impact birth weight, although impacts on infant mortality 
are less clear (see, e.g., Currie and Cole 1993; Baker 2008; Almond, Hoynes and 
Schanzenbach 2011; Hoynes, Miller, and Simon 2012). More generally, Cutler and 
Lleras-Muney (2010) document evidence that income plays a role in accounting 
for some of the education-health gradient in both the United States and the United 
Kingdom. If the poor in the United States are worse off than the poor elsewhere, 
then it is possible this drives some of the effects we observe.18 On the other hand, 
it is possible that these differences arise even within groups with similar incomes. 
If this is the case, it would suggest that excess postneonatal mortality in the United 
States is not a direct issue of income.
Ideally, we would address this question with individual-level data on income 
linked to birth outcomes. Unfortunately, such data are not accessible. As an alterna-
tive, we investigate this question using more aggregated data from the United States 
and Finland. Note that we are more confident in using these data for within-US com-
parisons, given that our income data are more comparable within the United States.
We approach this analysis, in both the cross-country and within-US case, by 
dividing individuals into deciles based on the mean income by their demographic 
cell. We then estimate the postneonatal mortality differences across countries and—
separately—the average difference across division-pairs in postneonatal mortality 
for each income decile. To the extent that differences in income drive the postneo-
natal mortality differences across areas, we should see limited differences in post-
neonatal mortality within income groups.
The results are shown in Table 8. They do not suggest similar mortality rates 
within income groups, at least not for low income individuals. When we compare 
the United States to Finland we find continued evidence of significantly elevated 
mortality rates in the United States even among groups with comparable income. 
For example, in the second income decile, the United States has a postneonatal 
mortality rate of 1.2 deaths per 1,000 more than Finland, despite virtually identical 
median incomes in this group across countries. Consistent with our earlier evidence, 
at the higher income levels there is no statistically significant postneonatal mortality 
gap across countries.
The GDP per capita in Finland is, on average, lower than the United States. As a 
result, if the United States adopted the Finnish income distribution, along with the 
US schedule of postneonatal mortality by income, infant mortality would actually 
be expected to increase. These cross-country results are, however, somewhat dif-
ficult to interpret given the vast differences in non-cash welfare provision by each 
country, which are not included in our income measures.
18 A related issue is that some authors have argued income inequality per se drives poor US birth outcomes 
(Reagan, Salsberry, and Olsen 2007), although the most recent evidence on this suggests it is probably not a robust 
relationship (Aizer, Higa and Winkler 2013). 
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Comfortingly, the estimates from our within-US analysis, shown in the right 
panel of Table 8, confirm the broad conclusions from our cross-country analysis. 
Even within fairly narrow income bins, there is large variation across census divi-
sions. In the poorest income decile, the average difference across division-pairs is 
1 death per 1,000. Among the higher income groups there is less variation, consis-
tent with the overall more limited variation in higher socioeconomic status groups 
demonstrated in Table 7.
Table 8—Postneonatal Disadvantage within Income Groups
  United States versus Finland Within United States across divisions
Excess US 
mortality,  
1–12 months
Median 
income, US 
[2005 US$]  
(after taxes)
Median 
income, 
Finland 
[2005 US$]  
(after taxes)
Average 
difference 
across 
divisions,  
1–12 months 
Median 
income, 
richest 
division
Median 
income, 
poorest 
division
(1) (2) (3)   (4) (5)
Income group 1 1.751*** $19,205 $20,583 0.987 $27,873 $23,421
(0.214) [1,040,820]
[1,055,295]
Income group 2 1.190*** $28,809 $27,892 0.631 $39,555 $37,284
(0.397) [1,040,783]
[1,054,913]
Income group 3 1.002*** $33,987 $34,367 0.580 $46,243 $45,101
(0.289) [1,043,016]
[1,058,082]
Income group 4 0.935*** $39,175 $38,788 0.366 $53,330 $52,622
(0.239) [1,038,100]
[1,090,286]
Income group 5 0.837** $43,993 $43,149 0.520 $60,748 $60,217
(0.380) [1,040,192]
[1,018,329]
Income group 6 0.886*** $49,230 $49,944 0.335 $68,886 $67,770
(0.256) [1,040,649]
[1,055,909]
Income group 7 0.540 $55,321 $57,139 0.276 $77,689 $76,507
(0.568) [1,040,475]
[1,058,485]
Income group 8 −0.348 $62,491 $59,225 0.184 $88,098 $86,244
(0.543) [1,040,587]
[1,054,957]
Income group 9 −2.109 $73,036 $71,529 0.185 $103,865 $101,755
(1.779) [1,047,361]
[1,055,930]
Income group 10 N/A $96,706 N/A 0.256 $153,357 $125,257
[1,056,316] [1,033,599]
notes: This table shows the postneonatal disadvantage by income group. Income data is defined for the households 
based on their location and demographic data. US income data comes from the IPUMS. Finnish income data comes 
from their Household Budget Survey. For the cross-country comparison, income is after tax for both countries; for 
the comparison within the United States, it is before tax. Income deciles are defined based on the entire sample. All 
figures are in units of 1,000 deaths: a coefficient of 1 indicates an increase of 1 death in 1,000 births. Robust stan-
dard errors are in parentheses. Number of observations on which the estimates are based are in square brackets. Data 
for all countries cover 2000–2005; as described in the text, the sample is limited to singleton births at  ≥ 22 weeks 
of gestation and  ≥ 500 grams with no missing covariates.
*** Significant at the 1 percent level.
 ** Significant at the 5 percent level.
  * Significant at the 10 percent level.
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We can summarize the importance of income in two ways. First, we estimate 
our basic regressions (i.e., column 5 of Table 5) but include detailed controls for 
income (we use $1,000 income bins); only 20 percent of the average division-pair 
gap is closed by the addition of these controls. Second, we ask what reduction in 
postneonatal mortality would be achieved if all census divisions were endowed 
with the income distribution of the richest census region (the Northeast); we esti-
mate that this would close 30 percent of the postneonatal mortality gap. Overall, 
this discussion suggests variation in postneonatal mortality rates across areas does 
not appear to be due to differences in income per se; notably, this is largely con-
sistent with an existing literature that finds that increasing resources per se does 
not have detectable effects on infant mortality in the United States (Baker 2008; 
Almond, Hoynes, and Schanzenbach 2011; Currie and Cole 1993; Hoynes, Miller, 
and Simon 2012).
V. Discussion and Conclusion
Our ultimate goal in understanding the US infant mortality disadvantage relative 
to Europe is to better understand what policy levers might be effective in reducing 
infant mortality in the United States. Our results on neonatal mortality strongly sug-
gest that differential access to technology-intensive medical care provided shortly 
after birth is unlikely to explain the US IMR disadvantage. This conclusion is, per-
haps, surprising in light of evidence that much of the decline in infant mortality in 
the 1950 to 1990 period was due to improvement in neonatal intensive care unit 
(NICU) technology (Cutler and Meara 2000). However, a variety of evidence sug-
gests that access to technology-intensive post-birth medical care should affect mor-
tality risks during the neonatal period, rather than during the postneonatal period: 
median time spent in the NICU is 13 days (March of Dimes 2011), and this care 
is thought to primarily affect neonatal mortality (see, for example, Rudolph and 
Borker 1987, Budetti et al. 1981, and Shaffer 2001). Consistent with this assertion, 
Almond et al. (2010) analyze the mortality consequences of incremental increases 
in medical expenditures for at-risk infants (including NICU admission as well as 
other expenditures), and find that the mortality benefits of additional medical care 
are concentrated in the first 28 days of life. Our results suggest that if anything the 
United States has a mortality advantage during the neonatal period.
Instead, the facts documented here suggest that, in general, policy attention 
should focus on either preventing preterm births or on reducing postneonatal mor-
tality. Although the former has received a tremendous amount of policy focus 
(MacDorman and Mathews 2009, Wilcox et al. 1995), the latter has to the best of 
our knowledge received very little attention. Our estimates suggest that decreasing 
postneonatal mortality in the United States to the level in Austria would lower US 
death rates by around 1 death per 1,000. Applying a standard value of a statistical 
life of US$7 million, this suggests it would be worth spending up to $7,000 per 
infant to achieve this gain. If policies were able to focus on individuals of lower 
socioeconomic status—given our estimates that advantaged groups do as well in 
the United States as elsewhere—even higher levels of spending per mother targeted 
would be justified.
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Identifying particular policies that could be effective in achieving these gains 
is beyond the scope of this paper and is an area that deserves more research atten-
tion. That said, one policy worth mentioning is home nurse visits. Both Finland and 
Austria, along with much of the rest of Europe, have policies that bring nurses or 
other health professionals to visit parents and infants at home. These visits com-
bine well-baby checkups with caregiver advice and support. Notably, in light of 
our income results, these policies do not focus on alleviating resource constraints 
per se but rather on providing information and support targeted to mothers and 
infants. While such small scale programs exist in the United States, they are far 
from universal, although provisions of the Affordable Care Act have expanded them 
to some extent. Randomized evaluations of such programs in the United States have 
shown evidence of mortality reductions, notably from causes of death we identify 
as important such as SIDS and accidents (Olds et al. 2007). To the extent that pro-
grams of this type are among the few available policy levers that focus on providing 
support to mothers and infants in the period after they are out of the hospital system, 
our evidence suggests they may be a clear place for future research.
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Appendix: Additional Tables and Figures
Figure A1. Distribution of Births by Gestational Age and Birth Weight, by Country
notes: This figure shows the distribution of gestational age and birth weight for each country. 
For ease of presentation, panel A is limited to births  > 30 weeks and panel B is limited to birth 
weights between 1,000 and 6,000 grams. Data for all countries covers 2000–2005; as described 
in the text, the sample is limited to singleton births at  ≥ 22 weeks of gestation and  ≥ 500 grams 
with both birth weight and gestational age observed.
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Table A1—Cross-Country Differences in Mortality: Robustness
Sample restriction < 1 week 1 week to 1 month 1 to 12 months
(1) (2) (3)
Panel A. United States versus Finland
Baseline −0.276*** 0.164*** 0.647***
(0.063) (0.033) (0.054)
Exclude births < 1,000gr −0.269*** 0.124*** 0.601***
(0.055) (0.030) (0.053)
Demographic controls −0.320*** 0.142*** 0.516***
(0.063) (0.033) (0.054)
Exclude Apgar < 9 0.027 0.123*** 0.672***
(0.036) (0.038) (0.084)
Exclude US blacks −0.218*** 0.145*** 0.496***
(0.063) (0.033) (0.054)
Exclude first births −0.422*** 0.111** 0.676***
(0.083) (0.044) (0.074)
Include multiple births −0.351*** 0.157*** 0.697***
(0.067) (0.035) (0.054)
     
Panel B. United States versus Austria
Baseline −0.019 0.068* 1.083***
(0.056) (0.036) (0.043)
Exclude births < 1,000gr 0.034 0.140*** 1.050***
(0.045) (0.029) (0.040)
Demographic controls −0.067 0.059 1.026***
(0.056) (0.037) (0.044)
Exclude Apgar < 9 −0.103*** 0.082*** 0.964***
(0.027) (0.025) (0.038)
Exclude US blacks 0.078 0.049 0.904***
(0.056) (0.036) (0.043)
Exclude first births −0.053 0.061 1.127***
(0.074) (0.048) (0.062)
Include multiple births −0.029 0.035 1.113***
(0.060) (0.039) (0.044)
notes: This table shows differences across countries in mortality, using either Finland 
(panel A) or Austria (panel B) as the omitted country, as in Table 3. Each cell shows the key 
estimate of interest from a different regression equation: the baseline as in Table 3 (row 1 in 
each panel); excluding births less than 1,000 grams (row 2 in each panel); including demo-
graphic controls (a quadratic in mother’s age in years; an indicator variable for whether the 
mother is currently married; an indicator variable for whether the child is male; and an indica-
tor variable for high education/occupation as defined in the text; row 3 in each panel); exclud-
ing infants with Apgar scores less than 9 (row 4 in each panel); excluding US blacks (row 5 
in each panel); excluding first births (row 6 in each panel); and including multiple births (row 
7 in each panel). The regressions adjust for 500 gram birth weight category cells. The regres-
sion results are conditional on reaching the minimum age: deaths up to one week; deaths from 
one week to one month, conditional on surviving to one week, etc. Coefficients are in units of 
1,000 deaths: a coefficient of 1 indicates an increase of 1 death in 1,000 births. Robust standard 
errors are in parentheses. Data for all countries covers 2000–2005; as described in the text, the 
sample is limited to singleton births at  ≥ 22 weeks of gestation and  ≥ 500 grams with birth 
weight and gestational age observed in all rows, and no missing covariates in rows 3 through 
7 of each panel.
*** Significant at the 1 percent level.
 ** Significant at the 5 percent level.
  * Significant at the 10 percent level.
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Table A2—Cross-Country Differences in Mortality, by Group (education only)
United States 
versus Austria
United States 
versus Finland
(1) (2)
United States 1.383*** 0.924***
(0.047) (0.062)
High SES −0.119 −0.272**
(0.114) (0.120)
United States × high SES −1.108*** −0.952***
(0.115) (0.121)
Observations 23,505,784 23,382,000
High SES, United States versus Europe 0.009 0.782
notes: This table shows differences across countries in mortality by advantaged versus disad-
vantaged group, as in Table 6, except that “advantaged” here is defined only as high education/
occupation. The regressions adjust for 500 gram birth weight category cells. The regression 
results are conditional on surviving to one month of age. Coefficients are in units of 1,000 
deaths: a coefficient of 1 indicates an increase of 1 death in 1,000 births. Robust standard errors 
are in parentheses. Data for all countries covers 2000–2005; as described in the text, the sam-
ple is limited to singleton births at  ≥ 22 weeks of gestation and  ≥ 500 grams with no miss-
ing covariates. The last row in each panel reports the p-value from a test for equality between 
the advantaged group in the United States relative to the advantaged group in the comparison 
country.
*** Significant at the 1 percent level.
 ** Significant at the 5 percent level.
  * Significant at the 10 percent level.
Table A3—Cross-Country Differences in Mortality,  
by Group (education + married only)
United States 
versus Austria
United States 
versus Finland
(1) (2)
United States 1.375*** 0.915***
(0.046) (0.061)
High SES and married −0.064 −0.320**
(0.132) (0.127)
United States × (high SES and married) −1.180*** −0.922***
(0.133) (0.128)
Observations 23,505,784 23,382,000
High SES and married, United States versus Europe 0.119 0.947
notes: This table shows differences across countries in mortality by advantaged versus disad-
vantaged group, as in Table 6, except that “advantaged” here is defined only as high education/
occupation and married. The regressions adjust for 500-gram birth weight category cells. The 
regression results are conditional on surviving to one month of age. Coefficients are in units of 
1,000 deaths: a coefficient of 1 indicates an increase of 1 death in 1,000 births. Robust standard 
errors are in parentheses. Data for all countries covers 2000-2005; as described in the text, the 
sample is limited to singleton births at  ≥ 22 weeks of gestation and  ≥ 500 grams with no miss-
ing covariates. The last row in each panel reports the p-value from a test for equality between 
the advantaged group in the US relative to the advantaged group in the comparison country.
*** Significant at the 1 percent level.
 ** Significant at the 5 percent level.
  * Significant at the 10 percent level.
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